16.98
+0.12(+0.71%)
Currency In USD
| Previous Close | 16.86 |
| Open | 16.9 |
| Day High | 17.3 |
| Day Low | 16.75 |
| 52-Week High | 18.22 |
| 52-Week Low | 3.78 |
| Volume | 350,916 |
| Average Volume | 322,170 |
| Market Cap | 315.23M |
| PE | -31.44 |
| EPS | -0.54 |
| Moving Average 50 Days | 13.88 |
| Moving Average 200 Days | 8.68 |
| Change | 0.12 |
If you invested $1000 in OptimizeRx Corporation (OPRX) 10 years ago, it would be worth $5,957.89 as of August 18, 2025 at a share price of $16.98. Whereas If you bought $1000 worth of OptimizeRx Corporation (OPRX) shares 5 years ago, it would be worth $975.3 as of August 18, 2025 at a share price of $16.98.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET
GlobeNewswire Inc.
Jul 17, 2025 11:30 AM GMT
WALTHAM, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients,
OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors
GlobeNewswire Inc.
Jun 24, 2025 11:30 AM GMT
WALTHAM, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients,
OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report
GlobeNewswire Inc.
May 01, 2025 8:05 PM GMT
WALTHAM, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, h